Suppr超能文献

在小鼠缓激肽伤害感受试验中,蛋白激酶C介导对外周μ-阿片类镇痛的急性耐受。

Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice.

作者信息

Inoue M, Ueda H

机构信息

Department of Molecular Pharmacology and Neuroscience, Nagasaki University School of Pharmaceutical Sciences, Nagasaki, Japan.

出版信息

J Pharmacol Exp Ther. 2000 May;293(2):662-9.

Abstract

We studied the acute tolerance liability of peripheral opioid analgesia in mice. The analgesia was assessed by the inhibition of bradykinin (BK)-induced nociceptive action by using a newly developed flexor reflex paradigm. Morphine [intraplantarly (i.pl.)] given ipsilaterally to BK showed a dose-dependent reduction of the BK (2 pmol) responses, whereas the administration of 10 nmol of morphine into the contralateral side failed to show any significant analgesic effects. Furthermore, DAMGO ([D-Ala(2),MePhe(4), Gly-ol(5)]-enkephalin), a mu-opioid receptor (MOR) agonist, and U-69593, a kappa-opioid receptor (KOR) agonist, but not DSLET ([D-Ser(2)]Leu-enkephalin-Thr(6)), a delta-opioid receptor agonist, showed similar analgesia on the BK responses. The morphine- or U-69593 [(5alpha,7alpha, 8beta)-(+)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5]dec -8yl] benzeneacetamide]-induced analgesia was markedly attenuated by the intrathecal injection of each antisense oligodeoxynucleotide for the MOR or KOR, respectively, suggesting that these peripheral analgesia are mediated through MORs and KORs located on nociceptor endings, respectively. As BK response was completely recovered to the control level 4 h after morphine (3 nmol i.pl.) or U-69593 (10 nmol i.pl.) administration, these compounds were challenged again to see the inhibition of BK responses. Although morphine analgesia by the second challenge was markedly attenuated, U-69593 analgesia was not. The attenuated morphine analgesia was completely reversed by the pretreatment of calphostin C, Go6976, or HBDDE, a protein kinase C inhibitor, but not by KT-5720, a protein kinase A inhibitor. These results suggest that selective acute tolerance of peripheral morphine analgesia, but not U-69593 analgesia, through MORs and KORs located on polymodal nociceptors, respectively, in the bradykinin-nociception test in mice was mediated through protein kinase C activation.

摘要

我们研究了小鼠外周阿片类镇痛的急性耐受倾向。通过使用新开发的屈肌反射范式,通过抑制缓激肽(BK)诱导的伤害性作用来评估镇痛效果。同侧给予BK的同时足底内注射吗啡显示出BK(2 pmol)反应呈剂量依赖性降低,而在对侧注射10 nmol吗啡未显示出任何显著的镇痛作用。此外,μ-阿片受体(MOR)激动剂DAMGO([D-Ala(2),MePhe(4),Gly-ol(5)]-脑啡肽)和κ-阿片受体(KOR)激动剂U-69593,但不是δ-阿片受体激动剂DSLET([D-Ser(2)]亮氨酸脑啡肽-Thr(6)),对BK反应显示出类似的镇痛作用。鞘内分别注射针对MOR或KOR的反义寡脱氧核苷酸后,吗啡[足底内(i.pl.)]或U-69593[(5α,7α,8β)-(+)-N-甲基-N-[7-(1-吡咯烷基)-1-氧杂螺[4,5]癸-8基]苯乙酰胺]诱导的镇痛作用明显减弱,这表明这些外周镇痛分别通过位于伤害感受器末梢的MOR和KOR介导。由于在注射吗啡(3 nmol i.pl.)或U-69593(10 nmol i.pl.)4小时后,BK反应完全恢复到对照水平,因此再次给予这些化合物以观察对BK反应的抑制作用。尽管第二次给药时吗啡镇痛作用明显减弱,但U-69593的镇痛作用并未减弱。蛋白激酶C抑制剂钙泊三醇C、Go6976或HBDDE预处理可完全逆转减弱的吗啡镇痛作用,但蛋白激酶A抑制剂KT-5720则不能。这些结果表明,在小鼠缓激肽-伤害感受试验中,外周吗啡镇痛而非U-69593镇痛通过分别位于多模式伤害感受器上的MOR和KOR产生的选择性急性耐受是由蛋白激酶C激活介导的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验